← Open Payments lookup

JAMES BIESINGER: Open Payments

NPI 1205885472 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,171 in 213 payments from 19 companies in 2025. Trend: 2023 $1,709 · 2024 $2,814 · 2025 $3,171

Food & beverage: $3,094Education: $77
CompanyPaymentsAmount
ABBVIE INC.52$770
Janssen Biotech, Inc.28$481
Aimmune Therapeutics, Inc.19$300
PFIZER INC.44$288
Ardelyx, Inc.13$244
Takeda Pharmaceuticals U.S.A., Inc.10$193
Celltrion USA Inc.8$189
Madrigal Pharmaceuticals9$175
Phathom Pharmaceuticals, Inc.9$137
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$87

Products named: TREMFYA, RINVOQ, IBSRELA, ZENPEP, XELJANZ, ENTYVIO, VEGZELMA, REZDIFFRA.

Industry payments across UT — which companies pay providers there.